The start-up plantoenter the top fifth in the clinical trial market worth of KRW 72 trillion

Published: 2014-12-08 10:59:08

Updated: 2014-12-08 10:59:08

The Korea National Enterprise for Clinical Trials (chairman Dong-hyunJi, KoNECT) will push ahead with a project to accomplish its vision for the ‘Top Fifth on Clinical Trials by 2020’.

The KoNECTannounced the new vision and mission at the celebration of its foundation, held in the Imperial Palace Hotel on the 4^th.

Chairman Dong-hyunJistated “Compared to other countries, Korea has relatively l...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.